Aethlon Medical(US:AEMD) Investorideas.com·2026-03-12 17:00Core Viewpoint - Aethlon Medical, Inc. (NASDAQ: AEMD) is exploring strategic opportunities with the assistance of Maxim Group LLC, which has led to a notable increase in stock price and trading volume [3][4][5]. Company Overview - Aethlon Medical, Inc. is a clinical-stage medical device company based in San Diego, California, focused on developing the Hemopurifier, a device aimed at treating cancer and life-threatening infectious diseases [8][9]. - The Hemopurifier has received FDA Breakthrough Device designation for treating advanced or metastatic cancer and life-threatening viruses [9]. Stock Performance - The stock price of Aethlon Medical increased by 4.81%, trading at $1.7300, with a day's high of $1.94 and a trading volume exceeding 859,000 shares [3][4]. Strategic Initiatives - The company has engaged Maxim Group LLC as its exclusive financial advisor to evaluate various strategic alternatives, including partnerships, mergers, and acquisitions [4][5]. - CEO James Frakes indicated that the company is actively pursuing development activities, including the completion of the second cohort of an Australian oncology trial [6]. Clinical Development - Aethlon Medical has completed the second cohort of its oncology trial in Australia, with safety data set to be submitted for review [6].